Suppr超能文献

[慢性血液透析患者的放射性核素研究。用于评估和控制肾性骨病的骨闪烁显像]

[Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].

作者信息

Dudczak R, Kletter K, Czembirek H, Derfler K, Marosi L, Salomonowitz E, Schmidt P, Wurzer G, Zazgornik J

出版信息

Wien Klin Wochenschr. 1984 Apr 27;96(9):326-32.

PMID:6236616
Abstract

The clinical applicability of bone scintigraphy (Tc99m MDP) was evaluated in 42 patients on maintenance hemodialysis. Typical scintigraphic findings are shown which were related to hormonal and biochemical parameters of calcium and phosphate metabolism. Visual grading of representative regions for metabolic bone disease in bone scans was compared to scintimetry which applies a bone to soft tissue ratio to grade osseous abnormalities. It could be shown that visual interpretation and grading of the findings according to a score is sufficient to assess the degree and extent of renal bone disease. Semiquantitative analysis of bone scintigrams by scintimetry did not improve the diagnostic information.

摘要

对42例维持性血液透析患者评估了骨闪烁显像(Tc99m亚甲基二膦酸盐)的临床适用性。展示了典型的闪烁显像结果,这些结果与钙和磷代谢的激素及生化参数相关。将骨扫描中代谢性骨病代表性区域的视觉分级与应用骨与软组织比值对骨异常进行分级的骨闪烁测定法进行了比较。结果表明,根据评分对结果进行视觉解读和分级足以评估肾性骨病的程度和范围。通过骨闪烁测定法对骨闪烁图进行半定量分析并未改善诊断信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验